Nucleus Raphes Magnus Expanded (Nrm) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Nucleus Raphes Magnus (NRM), also known as the raphe magnus, is a serotoninergic nucleus located in the midline of the medulla oblongata. It gives rise to descending serotonergic projections that modulate pain transmission in the spinal dorsal horn and plays critical roles in pain modulation, mood regulation, and autonomic function. [1]
| Attribute | Value | [2]
|-----------|-------| [3]
| Category | Serotonergic Brainstem Nuclei | [4]
| Location | Midline medulla, rostral to the inferior olive, ventral to the fourth ventricle | [5]
| Function | Pain modulation, analgesia, mood regulation, autonomic control | [6]
| Diseases | Chronic Pain, Depression, Parkinson's Disease, Alzheimer's Disease, Migraine, ALS, MSA | [7]
The NRM is a critical component of descending pain modulatory pathways: [8]
| Condition | NRM Involvement | Evidence | [9]
|-----------|-----------------|----------|
| Fibromyalgia | Hypofunction | Reduced 5-HT in CSF |
| Neuropathic Pain | Descending facilitation | RVM plasticity |
| Migraine | Trigeminovascular | 5-HT dysfunction |
| Complex Regional Pain | Autonomic dysregulation | Altered SSR binding |
| Drug Class | Target | Application |
|---|---|---|
| SSRIs | SERT | Depression, chronic pain |
| SNRIs | SERT, NET | Depression, fibromyalgia |
| Tricyclics | Multiple | Chronic pain, migraine |
| 5-HT1B/1D Agonists | Triptans | Migraine acute treatment |
The study of Nucleus Raphes Magnus Expanded (Nrm) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Besson JM, Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol Rev. 1987. ↩︎
Ren K, Dubner R. Descending modulation in persistent pain: An update. Pain. 2020. ↩︎
Millan MJ. Descending control of pain. Prog Neurobiol. 2002. ↩︎
Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002. ↩︎
Leong ML, Gu M, Speltz-Paiz R, et al. Neuronal loss in the rostral ventromedial medulla in a rat model of neuropathic pain. J Comp Neurol. 2011. ↩︎
Vanegas H, Schaible HG. Descending facilitatory pain modulatory systems. Pain. 2004. ↩︎
Fields HL, Heinricher MM, Mason P. Neurotransmitters in nociceptive modulatory neurons. Annu Rev Neurosci. 1991. ↩︎
Mössner R, et al. The serotonin transporter in psychiatric disorders. Cell Mol Neurobiol. 2006. ↩︎
Paulus PG, Sch标本 A. Serotonin and pain: A 2020 update. Pain. 2020. ↩︎